Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population

Zsuzsanna Nagy1, Oszkár Karádi, György Rumi

  • 1Department of Immunology and Rheumatology, Medical Faculty, University of Pécs, Irgalmasok utcája 1, 7621 Pécs, Hungary.

Insights

Genetic mutations in the CARD15/NOD2 gene are more prevalent in Hungarian Crohn's disease (CD) patients. Specific mutations, Arg702Trp and Leu1007fsinsC, are linked to earlier disease onset, suggesting their role in CD pathogenesis.

Area of Science:

  • Genetics
  • Immunology
  • Gastroenterology

Background:

  • Crohn's disease (CD) is an immune-mediated disorder influenced by genetic and environmental factors.
  • Mutations in the CARD15/NOD2 gene are implicated in CD pathogenesis, particularly in Caucasian populations.

Purpose of the Study:

  • To determine the allele frequency and clinical significance of three common CARD15/NOD2 mutations in Hungarian CD patients and healthy controls.
  • To investigate the association between specific CARD15/NOD2 mutations and disease characteristics in a Hungarian cohort.

Main Methods:

  • Genotyping of three common CARD15/NOD2 mutations (Arg702Trp, Gly908Arg, Leu1007fsinsC) using RFLP and ARMS techniques.
  • Analysis of demographic and clinical data from 74 CD patients and 107 healthy controls.
  • Statistical correlation of genetic findings with clinical parameters using chi(2) analysis.

Main Results:

  • Overall prevalence of CARD15/NOD2 mutations was significantly higher in Hungarian CD patients (33.78%) compared to controls (16.23%) (P < 0.025).
  • The Arg702Trp and Leu1007fsinsC mutations were more frequent in CD patients, while Gly908Arg showed no significant difference.
  • CARD15/NOD2 mutation carriers experienced an earlier onset of CD by approximately three years.

Conclusions:

  • Carriage of Arg702Trp and Leu1007fsinsC alleles in the CARD15/NOD2 gene is associated with Crohn's disease in the Hungarian population.
  • These findings support the role of CARD15/NOD2 in CD etiopathogenesis.
  • Genotyping of these CARD15/NOD2 mutations may aid in identifying high-risk individuals for Crohn's disease.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...